These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 32796077)

  • 1. A Mechanism-Based Targeted Screen To Identify Epstein-Barr Virus-Directed Antiviral Agents.
    Li X; Akinyemi IA; You JK; Rezaei MA; Li C; McIntosh MT; Del Poeta M; Bhaduri-McIntosh S
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of Epstein-Barr Virus by HIF-1α Requires p53.
    Kraus RJ; Cordes BA; Sathiamoorthi S; Patel P; Yuan X; Iempridee T; Yu X; Lee DL; Lambert PF; Mertz JE
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.
    Li X; Kozlov SV; El-Guindy A; Bhaduri-McIntosh S
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFI16 Partners with KAP1 to Maintain Epstein-Barr Virus Latency.
    Xu H; Li X; Rousseau BA; Akinyemi IA; Frey TR; Zhou K; Droske LE; Mitchell JA; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2022 Sep; 96(17):e0102822. PubMed ID: 35969079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a new class of small molecules that efficiently reactivate latent Epstein-Barr Virus.
    Tikhmyanova N; Schultz DC; Lee T; Salvino JM; Lieberman PM
    ACS Chem Biol; 2014 Mar; 9(3):785-95. PubMed ID: 24028149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prazoles Targeting Tsg101 Inhibit Release of Epstein-Barr Virus following Reactivation from Latency.
    Mannemuddhu SS; Xu H; Bleck CKE; Tjandra N; Carter C; Bhaduri-McIntosh S
    J Virol; 2021 Jun; 95(13):e0246620. PubMed ID: 33853959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Damage Signaling Is Induced in the Absence of Epstein-Barr Virus (EBV) Lytic DNA Replication and in Response to Expression of ZEBRA.
    Wang'ondu R; Teal S; Park R; Heston L; Delecluse H; Miller G
    PLoS One; 2015; 10(5):e0126088. PubMed ID: 25950714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation.
    Zhang Y; Jiang C; Trudeau SJ; Narita Y; Zhao B; Teng M; Guo R; Gewurz BE
    mBio; 2020 Oct; 11(5):. PubMed ID: 33109754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.
    Yetming KD; Lupey-Green LN; Biryukov S; Hughes DJ; Marendy EM; Miranda JL; Sample JT
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32581094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The danger molecule HMGB1 cooperates with the NLRP3 inflammasome to sustain expression of the EBV lytic switch protein in Burkitt lymphoma cells.
    Reinhart NM; Akinyemi IA; Frey TR; Xu H; Agudelo C; Brathwaite J; Burton EM; Burgula S; McIntosh MT; Bhaduri-McIntosh S
    Virology; 2022 Jan; 566():136-142. PubMed ID: 34922257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi M; Hermine O; Suarez F
    Front Immunol; 2018; 9():3060. PubMed ID: 30662441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-γ-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency.
    Pisano G; Roy A; Ahmed Ansari M; Kumar B; Chikoti L; Chandran B
    Virol J; 2017 Nov; 14(1):221. PubMed ID: 29132393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus's natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter.
    Kraus RJ; Yu X; Cordes BA; Sathiamoorthi S; Iempridee T; Nawandar DM; Ma S; Romero-Masters JC; McChesney KG; Lin Z; Makielski KR; Lee DL; Lambert PF; Johannsen EC; Kenney SC; Mertz JE
    PLoS Pathog; 2017 Jun; 13(6):e1006404. PubMed ID: 28617871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine.
    Anderson AG; Gaffy CB; Weseli JR; Gorres KL
    Viruses; 2019 May; 11(5):. PubMed ID: 31108875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole as a new drug to prevent Epstein-Barr virus reactivation.
    Thomé MP; Borde C; Larsen AK; Henriques JAP; Lenz G; Escargueil AE; Maréchal V
    Antiviral Res; 2019 Dec; 172():104615. PubMed ID: 31580916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.
    Hau PM; Deng W; Jia L; Yang J; Tsurumi T; Chiang AK; Huen MS; Tsao SW
    J Virol; 2015 Jan; 89(1):652-68. PubMed ID: 25355892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
    Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
    Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.
    Frey TR; Brathwaite J; Li X; Burgula S; Akinyemi IA; Agarwal S; Burton EM; Ljungman M; McIntosh MT; Bhaduri-McIntosh S
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin enhances lytic replication of Epstein-Barr virus in gastric carcinoma cells by increasing the transcriptional activities of immediate-early lytic promoters.
    Wang M; Wu W; Zhang Y; Yao G; Gu B
    Virus Res; 2018 Jan; 244():173-180. PubMed ID: 29169830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.